Sarepta Therapeutics | SRPT - 普通股股本



金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 571.15M
销售成本
USD 150.1M
流动资产
USD 2.22B
流动负债
USD 502.91M
债务
USD 1.04B
EBIT
USD 13.29M
EBITDA
USD 375.48M
员工
1.37K
EPS每股收益
USD 0.64
股本和储备
USD 1.53B
销售毛利
USD 251.15M
债务利息支出
USD 21.51M
利息收入
USD 7M
贷款资金
USD 847.62M
市值
USD 1.57B
净收入
USD 330.96M
营业费用
USD 387.96M
营业利润
USD 13.29M
普通股股本
USD 105.62M
PE价格收益
27.27
税前利润
USD -1.75M
销售收入
USD 401.3M
销售和管理费用
USD 107.6M
股票
USD 904.27M
贸易债权人
USD 50.98M
应收帐款人
USD 393.8M


普通股股本 更改 日
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amgen USD 541M 1000K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Daiichi Sankyo JPY 1.82B 30.68M 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Insmed USD 218.28M 1.76M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Neurocrine Biosciences USD 100.55M 50K 2026-06
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
PTC Therapeutics USD 82.88M 1.41M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Sarepta Therapeutics USD 105.62M 53K 2026-06
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Vertex Pharmaceuticals USD 253.3M 900K 2026-06